Sandu Pharmaceuticals Limited (SANDUPHQ.BO)
INR 50.23
(0.0%)
INR 50.23
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -11.43 Million INR | 49.77% |
| 2022 | -22.75 Million INR | -142.45% |
| 2021 | -9.38 Million INR | 79.18% |
| 2020 | -45.08 Million INR | -15985.59% |
| 2019 | 283.79 Thousand INR | -99.48% |
| 2018 | 54.28 Million INR | -32.6% |
| 2017 | 80.54 Million INR | -1.83% |
| 2016 | 82.04 Million INR | -24.07% |
| 2015 | 108.05 Million INR | 39.55% |
| 2014 | 77.43 Million INR | -1.56% |
| 2013 | 78.65 Million INR | 85.96% |
| 2012 | 42.29 Million INR | 48.66% |
| 2011 | 28.45 Million INR | 120.62% |
| 2010 | 12.89 Million INR | -21.02% |
| 2009 | 16.32 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | - INR | 100.0% |
| 2023 FY | -11.43 Million INR | 49.77% |
| 2023 Q4 | -11.43 Million INR | 0.0% |
| 2023 Q3 | - INR | 100.0% |
| 2023 Q2 | -15.54 Million INR | 0.0% |
| 2022 Q1 | - INR | 100.0% |
| 2022 FY | -22.75 Million INR | -142.45% |
| 2022 Q2 | -48.05 Million INR | 0.0% |
| 2022 Q3 | - INR | 100.0% |
| 2022 Q4 | -22.75 Million INR | 0.0% |
| 2021 Q1 | - INR | 100.0% |
| 2021 Q4 | -9.38 Million INR | 0.0% |
| 2021 Q3 | - INR | 100.0% |
| 2021 FY | -9.38 Million INR | 79.18% |
| 2021 Q2 | -16.11 Million INR | 0.0% |
| 2020 FY | -45.08 Million INR | -15985.59% |
| 2020 Q4 | -45.08 Million INR | 0.0% |
| 2020 Q2 | -11.67 Million INR | 0.0% |
| 2019 Q4 | 283.79 Thousand INR | 0.0% |
| 2019 FY | 283.79 Thousand INR | -99.48% |
| 2019 Q2 | 22.84 Million INR | 0.0% |
| 2018 FY | 54.28 Million INR | -32.6% |
| 2018 Q2 | 75.12 Million INR | 0.0% |
| 2018 Q4 | 54.28 Million INR | 0.0% |
| 2017 Q2 | 78.67 Million INR | 0.0% |
| 2017 FY | 80.54 Million INR | -1.83% |
| 2017 Q4 | 79.47 Million INR | 0.0% |
| 2016 FY | 82.04 Million INR | -24.07% |
| 2016 Q2 | 91.7 Million INR | 0.0% |
| 2016 Q4 | 73.3 Million INR | 0.0% |
| 2015 Q4 | 108.05 Million INR | 0.0% |
| 2015 Q2 | 46.29 Million INR | 0.0% |
| 2015 FY | 108.05 Million INR | 39.55% |
| 2014 Q4 | 77.43 Million INR | 0.0% |
| 2014 FY | 77.43 Million INR | -1.56% |
| 2014 Q2 | 83.94 Million INR | 0.0% |
| 2013 Q4 | 78.65 Million INR | 0.0% |
| 2013 Q2 | 63.85 Million INR | 0.0% |
| 2013 FY | 78.65 Million INR | 85.96% |
| 2012 Q4 | 42.29 Million INR | 0.0% |
| 2012 FY | 42.29 Million INR | 48.66% |
| 2011 FY | 28.45 Million INR | 120.62% |
| 2011 Q4 | 28.45 Million INR | 0.0% |
| 2010 FY | 12.89 Million INR | -21.02% |
| 2010 Q4 | 12.89 Million INR | 0.0% |
| 2009 FY | 16.32 Million INR | 0.0% |
| 2009 Q4 | 16.32 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 671.01 Million INR | 101.703% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 109.832% |
| Bacil Pharma Limited | 569 Thousand INR | 2108.787% |
| Beryl Drugs Limited | 48.7 Million INR | 123.466% |
| Cian Healthcare Limited | 544.97 Million INR | 102.097% |
| Colinz Laboratories Limited | -64.3 Million INR | 82.225% |
| Concord Drugs Limited | 164.48 Million INR | 106.949% |
| Deccan Health Care Limited | -7.07 Million INR | -61.532% |
| Gennex Laboratories Limited | -552.54 Million INR | 97.931% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | 130.267% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 76.236% |
| Kerala Ayurveda Limited | 447.82 Million INR | 102.552% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 101.24% |
| Mercury Laboratories Limited | -26.72 Million INR | 57.237% |
| Panchsheel Organics Limited | -157.82 Million INR | 92.758% |
| Parmax Pharma Limited | 51.8 Million INR | 122.061% |
| Parnax Lab Limited | 787.61 Million INR | 101.451% |
| Patidar Buildcon Limited | 25.12 Million INR | 145.491% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | 130.653% |
| Phaarmasia Limited | -4.89 Million INR | -133.408% |
| Sastasundar Ventures Limited | -297.24 Million INR | 96.155% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 74.386% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 80.49% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 101.092% |
| Sunil Healthcare Limited | 625.4 Million INR | 101.828% |
| Syschem (India) Limited | 3.53 Million INR | 423.613% |
| Trident Lifeline Limited | 117.56 Million INR | 109.723% |
| Transchem Limited | -3.16 Million INR | -261.366% |
| Tyche Industries Limited | -788.94 Million INR | 98.551% |
| Vikram Thermo (India) Limited | 38.62 Million INR | 129.592% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 84.991% |
| Zenith Healthcare Limited | -25.45 Million INR | 55.101% |
| Zenotech Laboratories Limited | -196.85 Million INR | 94.194% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | 145.333% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 102.648% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | -88.676% |
| MedPlus Health Services Limited | 8.67 Billion INR | 100.132% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 86.702% |
| Smruthi Organics Limited | 111.28 Million INR | 110.271% |
| Trimurthi Limited | -1.17 Million INR | -870.124% |
| Zenlabs Ethica Limited | 139.54 Million INR | 108.191% |
| Makers Laboratories Limited | 172.59 Million INR | 106.623% |
| Lactose (India) Limited | 373.97 Million INR | 103.056% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 101.658% |
| Roopa Industries Limited | 216.01 Million INR | 105.291% |
| PANJON LTD. | -12.8 Million INR | 10.759% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | 185.013% |
| Anuh Pharma Limited | -69.8 Million INR | 83.626% |
| Crestchem Limited | -1.45 Million INR | -688.276% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 81.18% |
| PRAVEG LIMITED | -434.98 Million INR | 97.372% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 101.095% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 83.256% |
| Norris Medicines Limited | 214.86 Million INR | 105.32% |
| Denis Chem Lab Limited | -236.28 Million INR | 95.163% |
| Veerhealth Care Limited | -2.38 Million INR | -379.245% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 98.557% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 102.001% |
| Godavari Drugs Limited | 530.02 Million INR | 102.157% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | -22.771% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 108.653% |
| Vivanza Biosciences Limited | 50.02 Million INR | 122.848% |
| Medi-Caps Limited | -3.21 Million INR | -255.632% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 87.728% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 105.662% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 78.788% |
| Bharat Parenterals Limited | 1.48 Billion INR | 100.768% |
| BDH Industries Limited | -164.47 Million INR | 93.05% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 114.523% |
| Coral Laboratories Limited | -612.82 Million INR | 98.135% |
| Evoq Remedies Limited | 41.14 Million INR | 127.778% |
| Trinity League India Limited | -12 Thousand INR | -95150.0% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 100.819% |
| Natural Capsules Limited | 956.68 Million INR | 101.195% |
| Auro Laboratories Limited | 252.51 Million INR | 104.526% |